Sort by
Refine Your Search
-
Category
-
Employer
- Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (formerly Institute of Genetics and Animal Biotechnology PAS)
- Adam Mickiewicz University
- Institute of Geological Sciences, Polish Academy of Sciences
- Institute of Human Genetics of the Polish Academy of Sciences
- MARIA CURIE-SKLODOWSKA UNIVERSITY IN LUBLIN
- Medical University of Gdańsk
- Medical University of Silesia
- Poznan University of Medical Sciences
- University of Warmia and Mazury
-
Field
-
; Presenting results at international conferences (oral presentations and posters); Participation in the GeoPlanet Doctoral School (https://www.ing.pan.pl/en/education/geoplanet-doctoral-school ); The place of
-
“Personalizing Affective Images with Generative Artificial Intelligence”, led by Maciej Behnke, PhD, DSc. Number of scholarships: 1 Host unit: Faculty of Physics and Astronomy, Adam Mickiewicz University, Poznań
-
Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (formerly Institute of Genetics and Animal Biotechnology PAS) | Poland | about 1 month ago
lymphomas, understand how its aberrant expression contributes to disease development, and develop effective strategies for targeting HDAC9 and monitoring its impact on BCL6 and p53. Project description: https
-
Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (formerly Institute of Genetics and Animal Biotechnology PAS) | Poland | about 1 month ago
to the admissions process for the Doctoral School of Animal and Health Sciences at IGAB PAS. Doctoral students admitted to the Doctoral School are required to comply with the School regulations https://www.igbzpan.pl
-
, research output with an Impact Factor (IF) of at least 40, or a research output score of at least 1500 points according to the ministerial scale, experience in teaching, communicative proficiency in spoken
-
student-scholarship holder at the Poznan Doctoral School of Institutes of Polish Academy of Sciences
of cancer cells to treatment is hypoxia in the tumor microenvironment. This phenomenon affects approximately 50–80% of patients with stage I–IV NSCLC and is a recognized poor prognostic factor. Despite
-
scientific development, publications, and conference visibility. Turn molecular insight into therapeutic strategy. This project offers the challenge, tools, and intellectual environment to launch a high-impact
-
.” The goal of this project is to investigate how anticancer drugs, antibiotics, and selected drug-like compounds interfere with protein biosynthesis and how these effects affect ribosome function, stress
-
sciences, in the biological sciences or biotechnology discipline; • significant publications in JCR journals with an Impact Factor; • practical experience in applying research techniques in the analysis
-
clinical decision-making within the framework of precision medicine. https://nastalylab.gumed.edu.pl THE RESPONSIBILITIES OF THE PERSON EMPLOYED IN THIS POSITION WILL INCLUDE: Co-leading R&D activities